Literature DB >> 10739160

Strong immunoreactivity of platelet-derived growth factor and its receptor at human and mouse neuromuscular junctions.

Y Zhao1, K Haginoya, K Iinuma.   

Abstract

Platelet-derived growth factor (PDGF) and its alpha-receptor were localized at human and mouse neuromuscular junctions (NMJs) using specific polyclonal antibodies against each, anti-PDGF-A and anti-PDGF alpha-receptor, respectively. By applying double fluorescence labeling, immunoreactivity for PDGF and its receptor was closely co-localized with acetylcholine receptors, which were identified with alpha-bungarotoxin. PDGF might be involved in the interaction between the presynaptic and postsynaptic components. This is the first demonstration of PDGF and its receptor concentrated at human and mouse NMJs.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10739160     DOI: 10.1620/tjem.189.239

Source DB:  PubMed          Journal:  Tohoku J Exp Med        ISSN: 0040-8727            Impact factor:   1.848


  3 in total

1.  Neuromuscular junction toxicity with tandutinib induces a myasthenic-like syndrome.

Authors:  T J Lehky; F M Iwamoto; T N Kreisl; M K Floeter; H A Fine
Journal:  Neurology       Date:  2011-01-18       Impact factor: 9.910

2.  Characterization of platelet-derived growth factor-A expression in mouse tissues using a lacZ knock-in approach.

Authors:  Johanna Andrae; Leonor Gouveia; Liqun He; Christer Betsholtz
Journal:  PLoS One       Date:  2014-08-28       Impact factor: 3.240

3.  Intramuscular Delivery of Gene Therapy for Targeting the Nervous System.

Authors:  Andrew P Tosolini; James N Sleigh
Journal:  Front Mol Neurosci       Date:  2020-07-17       Impact factor: 5.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.